Ledger.Open graph →
SEC Form D · filed March 16, 2021

Hoth Therapeutics, Inc

Offering
$15.0M
Sold
$15.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEW YORK, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

David Sarnoff · New York, NYDirectorWayne Linsley · New York, NYDirectorRobb Knie · New York, NYExec · DirectorGraig Springer · New York, NYDirectorDavid Briones · New York, NYExecVadim Mats · New York, NYDirectorRandall W. Mueller · O'Fallon, MOExec · DirectorGarth Ebanks · Grand Cayman, Cayman IslandsDirectorPatrick Trojer · Waltham, MAExecShelley Chu · Waltham, MADirectorSimon Read · Waltham, MADirectorStefanie Johns · New York, NYExecVadim Mats · NEW YORK, NYDirectorJeffery Sarrett · Denver, COExec · DirectorRachid Mallouk · Luxembourg, LuxembourgExecAndre G. Missuc · Luxembourg, LuxembourgDirectorTodd Berning · West Fargo, NDDirectorCarle Stenmark · San Francisco, CADirectorStefanie Johns · New York, NYExecVadim Mats · NEW YORK, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗